Investor Presentaiton slide image

Investor Presentaiton

US Business Update on US FDA inspections Last inspection Status post last inspection Manufacturing Facility Capability Bioequivalence Taloja (India) July 2021 Centre Formulations June 2021 Successfully closed inspection without any observations Received 2 observations. Already sent a detail response to the US FDA on the corrective and preventive actions being taken St. Louis (US) Baddi (India) Formulations February 2020 EIR# received in March 2020 Daman (India) Formulations August 2019 EIR# received in October 2019 California (US) APIs August 2018 EIR# received in October 2018 Ankleshwar (India) APIs December 2016 EIR# received in March 2017 Mandva (India) APIs September 2015 EIR# received in March 2016 O e ALKEM
View entire presentation